These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 8582960

  • 1. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
    Balasch J, Miró F, Burzaco I, Casamitjana R, Civico S, Ballescá JL, Puerto B, Vanrell JA.
    Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
    [Abstract] [Full Text] [Related]

  • 2. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG, Erb K, Laursen S, Rasmussen PE, Rex S.
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [Abstract] [Full Text] [Related]

  • 3. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R, Conway GS, Engmann L, Bekir JS, Jacobs HS.
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [Abstract] [Full Text] [Related]

  • 4. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R, Buckler HM, Matson P, Lieberman B, Burger HG, Hilton B, Horne G, Dyson M, Robertson WR.
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [Abstract] [Full Text] [Related]

  • 5. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z, Howles CM, Zalel Y, Weissman A, Insler V.
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [Abstract] [Full Text] [Related]

  • 6. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J, Fábregues F, Creus M, Moreno V, Puerto B, Peñarrubia J, Carmona F, Vanrell JA.
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [Abstract] [Full Text] [Related]

  • 7. Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle-stimulating hormone: the role of oestradiol.
    Fauser BC.
    Hum Reprod Update; 1997 Nov; 3(2):101-8. PubMed ID: 9286734
    [Abstract] [Full Text] [Related]

  • 8. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys.
    Zelinski-Wooten MB, Hutchison JS, Hess DL, Wolf DP, Stouffer RL.
    Hum Reprod; 1995 Jul; 10(7):1658-66. PubMed ID: 8582957
    [Abstract] [Full Text] [Related]

  • 9. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
    Teissier MP, Chable H, Paulhac S, Aubard Y.
    Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
    [Abstract] [Full Text] [Related]

  • 10. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin.
    Imthurn B, Macas E, Rosselli M, Keller PJ.
    Hum Reprod; 1996 Nov; 11(11):2387-91. PubMed ID: 8981116
    [Abstract] [Full Text] [Related]

  • 11. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH, Agdi M, Shehata F, Son W, Tan SL.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [Abstract] [Full Text] [Related]

  • 12. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone.
    Develioglu OH, Cox B, Toner JP, Oehninger S, Muasher SJ.
    Hum Reprod; 1999 May; 14(5):1168-74. PubMed ID: 10325255
    [Abstract] [Full Text] [Related]

  • 13. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI, Lobo RA, Campeau JD, Tsai HM, Holmberg EA, Ono T, Frederick JJ, Platt LD, diZerega GS.
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [Abstract] [Full Text] [Related]

  • 14. The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women.
    Jones GS, Acosta AA, Garcia JE, Bernardus RE, Rosenwaks Z.
    Fertil Steril; 1985 May; 43(5):696-702. PubMed ID: 3922799
    [Abstract] [Full Text] [Related]

  • 15. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ, Townson DH, Friedman CI, Danforth DR.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [Abstract] [Full Text] [Related]

  • 17. Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation.
    Cahill DJ, Prosser CJ, Wardle PG, Ford WC, Hull MG.
    Br J Obstet Gynaecol; 1994 Nov; 101(11):999-1002. PubMed ID: 7999732
    [Abstract] [Full Text] [Related]

  • 18. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of HMG or pure FSH stimulation during suppression with an LHRH agonist analogue.
    Török A, Hamori M, Tinneberg HR, Cledon P, Gagsteiger F, Hanf V.
    Hum Reprod; 1991 Aug; 6(7):922-4. PubMed ID: 1662226
    [Abstract] [Full Text] [Related]

  • 20. Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination.
    Mercan R, Mayer JF, Walker D, Jones S, Oehninger S, Toner JP, Muasher SJ.
    Hum Reprod; 1997 Sep; 12(9):1886-9. PubMed ID: 9363700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.